Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER CHEN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1851603674
CMS profile
39137
Location
TUCSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$92,001.03

418 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Pharmacosmos Therapeutics Inc. $57,920.56 103
Incyte Corporation $22,580.58 33
Regeneron Pharmaceuticals, Inc. $3,718.75 3
AstraZeneca Pharmaceuticals LP $1,952.75 26
Novartis Pharmaceuticals Corporation $406.25 20
Janssen Biotech, Inc. $399.26 22
PFIZER INC. $380.52 19
Merck Sharp & Dohme LLC $360.37 15
Astellas Pharma US Inc $272.06 5
Takeda Pharmaceuticals U.S.A., Inc. $202.95 8
Genentech USA, Inc. $194.50 8
E.R. Squibb & Sons, L.L.C. $191.26 9
Gilead Sciences, Inc. $190.86 7
ABBVIE INC. $175.47 11
Celgene Corporation $175.13 9
Eisai Inc. $166.58 7
GlaxoSmithKline, LLC. $162.99 12
Daiichi Sankyo Inc. $155.00 9
Galderma Laboratories, L.P. $146.99 1
Genmab U.S., Inc. $131.83 4
Aadi Bioscience, Inc. $124.60 2
GENZYME CORPORATION $118.20 5
Bayer Healthcare Pharmaceuticals Inc. $95.35 5
ARRAY BIOPHARMA INC $86.84 4
SHIELD THERAPEUTICS INC $84.72 1
SOBI, INC $83.66 4
Karyopharm Therapeutics Inc. $77.88 4
Blueprint Medicines Corporation $76.38 3
Stemline Therapeutics Inc. $70.78 3
Menarini Silicon Biosystems, Inc. $66.94 2
PROTEGA PHARMACEUTIALS INC $60.82 1
Rigel Pharmaceuticals, Inc. $60.27 3
Boehringer Ingelheim Pharmaceuticals, Inc. $59.31 2
SERVIER PHARMACEUTICALS LLC $56.21 3
Aveo Pharmaceuticals, Inc. $55.93 3
Alexion Pharmaceuticals, Inc. $55.74 3
Tactile Systems Technology Inc $52.77 1
Mirati Therapeutics, Inc. $51.75 3
Regeneron Healthcare Solutions, Inc. $50.57 2
EMD Serono, Inc. $49.10 2
Myriad Genetic Laboratories, Inc. $48.54 2
Ipsen Biopharmaceuticals, Inc $46.13 2
SpringWorks Therapeutics, Inc. $44.63 2
PUMA BIOTECHNOLOGY, INC. $43.80 2
Exelixis Inc. $40.19 2
PharmaEssentia USA Corporation $39.50 2
TerSera Therapeutics LLC $36.05 1
BeiGene USA, Inc. $32.90 2
Kyowa Kirin, Inc. $29.18 1
JAZZ PHARMACEUTICALS INC. $27.92 2
SUN PHARMACEUTICAL INDUSTRIES INC. $27.40 1
TAIHO ONCOLOGY, INC. $25.90 1
Kite Pharma, Inc. $25.47 1
Adaptive Biotechnologies Corporation $25.45 1
Blue Earth Diagnostics Limited $24.42 1
Lilly USA, LLC $23.75 1
RECORDATI_RARE_DISEASES_INC. $22.60 1
ImmunoGen, Inc. $22.06 1
Digestive Care, Inc. $22.02 1
Sumitomo Pharma America, Inc. $20.55 1
Apellis Pharmaceuticals, Inc. $17.57 1
Deciphera Pharmaceuticals Inc. $17.54 1
Immunocore Limited $14.98 1

Page 2 of 9; records 51–100 of 418 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER CHEN

NPI 1851603674 · CMS profile ID 39137

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

TUCSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 9; records 51–100 of 418 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851603674?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER CHEN, NPI 1851603674, CMS profile ID 39137. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 418 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851603674?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CHRISTOPHER CHEN, NPI 1851603674, CMS profile ID 39137. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 418 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851603674?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CHRISTOPHER CHEN, NPI 1851603674, CMS profile ID 39137, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 418 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1851603674?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

418 matching records · $92,001.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 418 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 418.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $23.9811/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131389821 CMS
Pharmacosmos Therapeutics Inc. $149.5511/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820849 CMS
Pharmacosmos Therapeutics Inc. $6,313.5011/07/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820851 CMS
Daiichi Sankyo Inc. $27.5511/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089408200 CMS
Janssen Biotech, Inc. $30.8911/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078284861 CMS
Janssen Biotech, Inc. $30.8911/06/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1176587649 CMS
Karyopharm Therapeutics Inc. $16.4711/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145528548 CMS
Alexion Pharmaceuticals, Inc. $24.5211/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093999370 CMS
Genentech USA, Inc. $14.3710/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132988989 CMS
TerSera Therapeutics LLC $36.0510/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144713535 CMS
Genentech USA, Inc. $33.2510/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132989006 CMS
Pharmacosmos Therapeutics Inc. $85.8510/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820841 CMS
Pharmacosmos Therapeutics Inc. $10.0010/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820843 CMS
Pharmacosmos Therapeutics Inc. $33.5010/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820845 CMS
Pharmacosmos Therapeutics Inc. $38.0010/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820847 CMS
GENZYME CORPORATION $28.7710/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139855453 CMS
E.R. Squibb & Sons, L.L.C. $9.7310/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101586374 CMS
Galderma Laboratories, L.P. $146.9910/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145290176 CMS
Pharmacosmos Therapeutics Inc. $192.2910/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820835 CMS
Pharmacosmos Therapeutics Inc. $807.9610/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820837 CMS
Pharmacosmos Therapeutics Inc. $84.2210/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820839 CMS
Gilead Sciences, Inc. $3.8510/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133804012 CMS
Janssen Biotech, Inc. $16.7710/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078284057 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.8710/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086108638 CMS
PFIZER INC. $17.5310/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130875352 CMS
Rigel Pharmaceuticals, Inc. $15.1110/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145209021 CMS
Merck Sharp & Dohme LLC $24.1410/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141830252 CMS
Novartis Pharmaceuticals Corporation $24.1810/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086671157 CMS
AstraZeneca Pharmaceuticals LP $25.9610/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105775906 CMS
AstraZeneca Pharmaceuticals LP $28.5210/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104231349 CMS
Celgene Corporation $26.3910/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101159316 CMS
Novartis Pharmaceuticals Corporation $12.4110/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086671129 CMS
EMD Serono, Inc. $26.9610/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120263060 CMS
Ipsen Biopharmaceuticals, Inc $23.7410/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091963441 CMS
Janssen Biotech, Inc. $14.3610/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078284781 CMS
Merck Sharp & Dohme LLC $16.1610/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141582267 CMS
ABBVIE INC. $27.3509/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103451800 CMS
Daiichi Sankyo Inc. $6.3409/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089408328 CMS
Pharmacosmos Therapeutics Inc. $44.3509/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820827 CMS
Pharmacosmos Therapeutics Inc. $15.0009/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820829 CMS
Pharmacosmos Therapeutics Inc. $40.0709/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820831 CMS
Pharmacosmos Therapeutics Inc. $4,117.5009/25/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154820833 CMS
AstraZeneca Pharmaceuticals LP $20.9409/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104313934 CMS
Celgene Corporation $18.8409/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101159318 CMS
SERVIER PHARMACEUTICALS LLC $20.5609/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147258740 CMS
AstraZeneca Pharmaceuticals LP $30.4709/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105687791 CMS
Takeda Pharmaceuticals U.S.A., Inc. $11.7809/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144955267 CMS
SOBI, INC $14.8409/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141438637 CMS
ABBVIE INC. $24.5509/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103451798 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.4109/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144955265 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $30,444.27 170
PY2020 $30,618.86 151
PY2021 $30,431.72 175
PY2022 $68,470.25 309
PY2023 $57,230.11 206
PY2024 $92,001.03 418
PY2025 $60,455.21 213

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,250.00 1
PY2023 Principal investigator $28,787.50 6
PY2022 Principal investigator $3,000.00 1
PY2021 Principal investigator $14,750.00 5
PY2020 Principal investigator $24,950.00 5
PY2019 Principal investigator $44,888.97 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Mirati Therapeutics, Inc. $2,250.00 02/21/2024 Non-covered Recipient Entity
Innovative Clinical Research Institute
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy S No dispute reported 06/30/2026 1124763980